UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Q: What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in Q2 2018?

60 institutional investors reported URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: M96088105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 46,986,408
Total 13F shares: 9,602,369
Share change: +472,929
Total reported value: $482,439,000
Price per share: $49.76
Number of holders: 60
Value change: +$24,129,548
Number of buys: 44
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP M96088105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	4.4%	2,045,629	$101,647,000	—	31 Mar 2018	13F
Consonance Capital Management LP	13F	Company	2.4%	1,146,197	$56,955,000	—	31 Mar 2018	13F
ProQuest Associates IV LLC	13F	Company	2.3%	1,096,024	$54,461,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2%	939,875	$46,703,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	1.8%	864,427	$42,953,000	—	31 Mar 2018	13F
MEITAV INVESTMENT HOUSE LTD	13F	Company	0.95%	447,352	$22,229,000	—	31 Mar 2018	13F
EcoR1 Capital, LLC	13F	Company	0.86%	402,300	$19,990,000	—	31 Mar 2018	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	0.8%	376,823	$18,724,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	0.75%	352,000	$17,491,000	—	31 Mar 2018	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	0.6%	283,500	$14,087,000	—	31 Mar 2018	13F
DSAM Partners (London) Ltd	13F	Company	0.41%	194,250	$9,652,000	—	31 Mar 2018	13F
Wildcat Capital Management, LLC	13F	Company	0.39%	181,702	$9,029,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.34%	159,113	$7,906,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	156,700	$7,786,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	81,358	$4,043,000	—	31 Mar 2018	13F
BANK HAPOALIM BM	13F	Company	0.11%	52,300	$2,599,000	—	31 Mar 2018	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.1%	45,575	$2,265,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	44,699	$2,221,000	—	31 Mar 2018	13F
Lyon Street Capital, LLC	13F	Company	0.07%	32,841	$1,632,000	—	31 Mar 2018	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.07%	31,416	$1,561,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	29,659	$1,473,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.06%	28,857	$1,434,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.05%	25,000	$1,242,000	—	31 Mar 2018	13F
ALPS ADVISORS INC	13F	Company	0.04%	20,406	$1,014,000	—	31 Mar 2018	13F
Coastal Bridge Advisors, LLC	13F	Company	0.04%	19,230	$956,000	—	31 Mar 2018	13F
ARK Investment Management LLC	13F	Company	0.03%	13,502	$671,000	—	31 Mar 2018	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.03%	12,250	$609,000	—	31 Mar 2018	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.02%	8,161	$395,000	—	31 Mar 2018	13F
Virtu Financial LLC	13F	Company	0.02%	7,637	$379,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	7,145	$355,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.01%	5,315	$264,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	5,050	$251,000	—	31 Mar 2018	13F
DAFNA Capital Management LLC	13F	Company	0.01%	4,500	$224,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.01%	3,611	$180,000	—	31 Mar 2018	13F
Quantbot Technologies LP	13F	Company	0.01%	3,518	$174,000	—	31 Mar 2018	13F
VAN ECK ASSOCIATES CORP	13F	Company	0.01%	3,026	$150,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	2,073	$103,000	—	31 Mar 2018	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0%	1,100	$55,000	—	31 Mar 2018	13F
MCKINLEY CAPITAL MANAGEMENT LLC	13F	Company	0%	1,013	$50,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	990	$49,000	—	31 Mar 2018	13F
Parallel Advisors, LLC	13F	Company	0%	900	$45,000	—	31 Mar 2018	13F
Catalyst Capital Advisors LLC	13F	Company	0%	380	$19,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	197	$10,000	—	31 Mar 2018	13F

Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2018

As of 30 Jun 2018, UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,602,369 shares. The largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., Consonance Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, ProQuest Associates IV LLC, FMR LLC, MEITAV DASH INVESTMENTS LTD, HIGHLINE CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, Clal Insurance Enterprises Holdings Ltd, and CREDIT SUISSE AG/. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.